LXRX Stock Analysis: Buy, Sell, or Hold?

LXRX - Lexicon Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS
$2.16
0.01 (0.47%) ▲
5d: +10.2%
30d: -3.14%
90d: +31.71%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation

None View Scanner →

Strength: 5.6/10

Get Alerted When LXRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: LXRX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: LXRX is currently trading at $2.16, which is considered slightly high relative to its 30-day fair value range of $1.91 to $2.17.

Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.84, while resistance sits at $2.23.

Market Sentiment: LXRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.77 (+74.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.91 - $2.17
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.9%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 74.5% below Wall St target ($3.77)

Trading Range Analysis

30-Day Trading Range $1.91 - $2.17
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.84
Resistance Level $2.24
Current Trend Strong Uptrend
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -10.47
Wall Street Target $3.77 (+74.5%)
Revenue Growth (YoY) 1572.1%
Earnings Growth (YoY) -63.4%
Profit Margin -37.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 5:20 AM ET
Data refreshes hourly during market hours. Next update: 6:20 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Raymond Debbane BUY 2000 shares 2026-02-25
Raymond Debbane BUY 100000 shares 2026-02-23
Raymond Debbane BUY 100000 shares 2026-02-20

Unlock Insider Activity

See real-time buying/selling by company executives for LXRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 67 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$105 64 BUY
VRDN
Viridian Therapeutics Inc
STRONG BUY
16 analysts
$34 61 BUY
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
12 analysts
$20 61 BUY
MNMD
Mind Medicine Inc
STRONG BUY
11 analysts
$29 62 BUY

More Analysis for LXRX

LXRX Technical Chart LXRX Price Prediction LXRX Earnings Date LXRX Investment Advisor LXRX Fair Price Analyzer LXRX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals